Targeting Raf Kinase Inhibitory Protein Regulation and Function
AbstractRaf Kinase Inhibitory Protein (RKIP) is a highly conserved kinase inhibitor that functions as a metastasis suppressor in a variety of cancers. Since RKIP can reprogram tumor cells to a non-metastatic state by rewiring kinase networks, elucidating the mechanism by which RKIP acts not only reveals molecular mechanisms that regulate metastasis, but also represents an opportunity to target these signaling networks therapeutically. Although RKIP is often lost during metastatic progression, the mechanism by which this occurs in tumor cells is complex and not well understood. In this review, we summarize our current understanding of RKIP regulation in tumors and consider experimental and computational strategies for recovering or mimicking its function by targeting mediators of metastasis. View Full-Text
Share & Cite This Article
Yesilkanal, A.E.; Rosner, M.R. Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers 2018, 10, 306.
Yesilkanal AE, Rosner MR. Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers. 2018; 10(9):306.Chicago/Turabian Style
Yesilkanal, Ali E.; Rosner, Marsha R. 2018. "Targeting Raf Kinase Inhibitory Protein Regulation and Function." Cancers 10, no. 9: 306.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.